Issue 1/2019
Content (24 Articles)
Concurrent versus non-concurrent immune checkpoint inhibition with stereotactic radiosurgery for metastatic brain disease: a systematic review and meta-analysis
Victor M. Lu, Anshit Goyal, Richard A. Rovin, Adrian Lee, Kerrie L. McDonald
Fluorescence-guided surgery with aminolevulinic acid for low-grade gliomas
Benjamin K. Hendricks, Nader Sanai, Walter Stummer
MiR-101-3p inhibits EMT to attenuate proliferation and metastasis in glioblastoma by targeting TRIM44
Ling Li, Mei-Ying Shao, Shu-Cheng Zou, Zhe-Feng Xiao, Zhu-Chu Chen
Loss of programmed cell death 10 activates tumor cells and leads to temozolomide-resistance in glioblastoma
Ann-Christin Nickel, Xue-Yan Wan, Dino-Vitali Saban, Yin-Lun Weng, Shu Zhang, Kathy Keyvani, Ulrich Sure, Yuan Zhu
Functional relevance of genes predicted to be affected by epigenetic alterations in atypical teratoid/rhabdoid tumors
Isabel Tegeder, Katharina Thiel, Serap Erkek, Pascal D. Johann, Johannes Berlandi, Venu Thatikonda, Michael C. Frühwald, Marcel Kool, Astrid Jeibmann, Martin Hasselblatt
A cancer tissue-specific FAM72 expression profile defines a novel glioblastoma multiform (GBM) gene-mutation signature
Chinmay Satish Rahane, Arne Kutzner, Klaus Heese
Lower expression of Bax predicts poor clinical outcome in patients with glioma after curative resection and radiotherapy/chemotherapy
Pei-Guo Wang, Yu-Ting Li, Yi Pan, Zhen-Zhu Gao, Xu-Wen Guan, Li Jia, Feng-Ting Liu
Combined intracavitary thermotherapy with iron oxide nanoparticles and radiotherapy as local treatment modality in recurrent glioblastoma patients
Oliver Grauer, Mohammed Jaber, Katharina Hess, Matthias Weckesser, Wolfram Schwindt, Stephan Maring, Johannes Wölfer, Walter Stummer
RNA-seq for identification of therapeutically targetable determinants of immune activation in human glioblastoma
Stephen J. Bagley, Wei-Ting Hwang, Steven Brem, Gerald P. Linette, Donald M. O’Rourke, Arati S. Desai
Large volume re-irradiation for recurrent meningioma with pulsed reduced dose rate radiotherapy
Jacob S. Witt, Hima B. Musunuru, R. Adam Bayliss, Steven P. Howard
Imaging tryptophan uptake with positron emission tomography in glioblastoma patients treated with indoximod
Rimas V. Lukas, Csaba Juhász, Derek A. Wainwright, Charles David James, Eugene Kennedy, Roger Stupp, Maciej S. Lesniak
Tubular brain tumor biopsy improves diagnostic yield for subcortical lesions
Evan D. Bander, Samuel H. Jones, David Pisapia, Rajiv Magge, Howard Fine, Theodore H. Schwartz, Rohan Ramakrishna
TERT promoter methylation is significantly associated with TERT upregulation and disease progression in pituitary adenomas
Yohei Miyake, Jun-ichi Adachi, Tomonari Suzuki, Kazuhiko Mishima, Ryuichiro Araki, Reina Mizuno, Ryo Nishikawa
Survival of glioma patients in relation to mobile phone use in Denmark, Finland and Sweden
Ann Olsson, Liacine Bouaoun, Anssi Auvinen, Maria Feychting, Christoffer Johansen, Tiit Mathiesen, Beatrice Melin, Anna Lahkola, Suvi Larjavaara, Anne-Sophie Villegier, Graham Byrnes, Isabelle Deltour, Joachim Schüz
Use of hyperbaric oxygen therapy in pediatric neuro-oncology: a single institutional experience
Yasmin Aghajan, Ian Grover, Hamza Gorsi, Mark Tumblin, John Ross Crawford
The impact of traveling distance and hospital volume on post-surgical outcomes for patients with glioblastoma
Christian Lopez Ramos, Michael G. Brandel, Jeffrey A. Steinberg, Arvin R. Wali, Robert C. Rennert, David R. Santiago-Dieppa, Reith R. Sarkar, J. Scott Pannell, James D. Murphy, Alexander A. Khalessi
Effects of surgery on neurocognitive function in patients with glioma: a meta-analysis of immediate post-operative and long-term follow-up neurocognitive outcomes
Justin Choon Hwee Ng, Angela An Qi See, Ting Yao Ang, Lysia Yan Rong Tan, Beng Ti Ang, Nicolas Kon Kam King
The role of frameless stereotactic biopsy in contemporary neuro-oncology: molecular specifications and diagnostic yield in biopsied glioma patients
Marius Marc-Daniel Mader, Roman Rotermund, Tobias Martens, Manfred Westphal, Jakob Matschke, Tammam Abboud
Comparative analysis of the diffusion kurtosis imaging and diffusion tensor imaging in grading gliomas, predicting tumour cell proliferation and IDH-1 gene mutation status
Jing Zhao, Yu-liang Wang, Xin-bei Li, Man-shi Hu, Zhu-hao Li, Yu-kun Song, Jing-yan Wang, Yi-su Tian, Da-wei Liu, Xu Yan, Li Jiang, Zhi-yun Yang, Jian-ping Chu
Eighty percent survival rate at 15 years for 1p/19q co-deleted oligodendroglioma treated with upfront chemotherapy irrespective of tumor grade
Yasuo Iwadate, Tomoo Matsutani, Ayaka Hara, Seiichiro Hirono, Shiro Ikegami, Masayoshi Kobayashi, Daisuke Ito, Daisuke Kawauchi, Kentaro Horiguchi, Ado Tamiya, Yoshinori Higuchi
Management and survival trends for adult patients with malignant gliomas in the setting of multiple primary tumors: a population based analysis
Ha Son Nguyen, Ninh B. Doan, Michael Gelsomino, Saman Shabani, Ahmed J. Awad, Mayank Kaushal, Martin M. Mortazavi
Surgical management of lower-grade glioma in the spotlight of the 2016 WHO classification system
Daniel Delev, Dieter Henrik Heiland, Pamela Franco, Peter Reinacher, Irina Mader, Ori Staszewski, Silke Lassmann, Stefan Grau, Oliver Schnell
Mild cognitive impairment in long-term brain tumor survivors following brain irradiation
Christina K. Cramer, Neil McKee, L. Doug Case, Michael D. Chan, Tiffany L. Cummings, Glenn J. Lesser, Edward G. Shaw, Stephen R. Rapp
Brain T1ρ mapping for grading and IDH1 gene mutation detection of gliomas: a preliminary study
Mengqiu Cao, Weina Ding, Xu Han, Shiteng Suo, Yawen Sun, Yao Wang, Jianxun Qu, Xiaohua Zhang, Yan Zhou